Future Health ESG PE Ratio 2022-2023 | FHLT
Current and historical p/e ratio for Future Health ESG (FHLT) from 2022 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Future Health ESG PE ratio as of May 30, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Future Health ESG PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-29 | 10.96 | 0.00 | |
| 2023-12-31 | 10.67 | 0 | 0.00 |
| 2023-09-30 | 10.55 | 0 | 0.00 |
| 2023-06-30 | 10.28 | 0 | 0.00 |
| 2023-03-31 | 9.90 | 0 | 0.00 |
| 2022-12-31 | 10.10 | 0 | 0.00 |
| 2022-09-30 | 10.01 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Future Health ESG Corp. entered into a definitive business combination agreement with Excelera DCE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.399B | 58.01 |
| Hims & Hers Health (HIMS) | United States | $11.729B | 121.86 |
| Tempus AI (TEM) | United States | $9.423B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.541B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.078B | 63.71 |
| Privia Health (PRVA) | United States | $2.749B | 187.92 |
| Enovis (ENOV) | United States | $1.831B | 10.21 |
| Clover Health Investments (CLOV) | United States | $1.593B | 0.00 |
| Schrodinger (SDGR) | United States | $1.573B | 0.00 |
| Phreesia (PHR) | United States | $1.454B | 0.00 |
| Omnicell (OMCL) | United States | $1.397B | 24.65 |
| Azenta (AZTA) | United States | $1.251B | 58.15 |
| 10x Genomics (TXG) | United States | $1.149B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.627B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.601B | 0.00 |
| Claritev (CTEV) | United States | $0.591B | 0.00 |
| Talkspace (TALK) | United States | $0.549B | 164.00 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.403B | 0.00 |
| TruBridge (TBRG) | United States | $0.358B | 793.67 |
| Outset Medical (OM) | United States | $0.312B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| Pulmonx (LUNG) | United States | $0.129B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.128B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
| CareCloud (CCLD) | United States | $0.090B | 3.42 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |